Most Recent Articles by Christina T. Loguidice
Two HIV experts discuss their ongoing research involving HIV in aging adults and provide insights on how some major health concerns can be addressed to improve the overall care and outcomes of older adults with HIV.
Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name drugs are coming off patent. But unique challenges surrounding their use remain.
Prompt diagnosis of tick-borne diseases is essential but testing methods have been imprecise. Learn about some recent testing advances for Lyme disease and other tick-borne illnesses.
The availability of low-cost generic DAAs in lower income countries are a major step forward in combating HCV in these countries, but substantial work is still needed to put the WHO's goal of HCV elimination by 2030 within reach.
The opioid epidemic has fueled the transmission of HCV, particularly among younger persons, who are often unaware of their risks and prevented from receiving timely treatment due to a variety of care barriers, even in settings ideally suited to identifying and treating HCV.
More Articles by Christina T. Loguidice
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Isavuconazole Not Noninferior to Caspofungin for Invasive Candida Infections
- Three New Ebola Vaccines Demonstrate Persistent Immune Response
- Dundee Severity Classification Improves Management of Patients With Cellulitis
- Pregnant Women Commonly Refuse Vaccines
- Tap Water in Neti Pot Linked to Death From Brain-Eating Amoeba
- Prenatal Malaria Exposure Modulates Innate Immune Responses at Birth
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- A Single Triple-Drug Treatment for Lymphatic Filariasis
- Cyclosporiasis Cases Markedly Higher in 2018 Than Previous 2 Years
- Mail-Based HPV Testing May Increase Access